Alaunos Therapeutics (TCRT) Analyst & Key Data

Analyst Consensus

Hold10 analysts

Hold

Updated Sep 12, 2026

Total Analysts10

Buy

1

Hold

8

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.51

DCF Value-78.17%

$0.33

Potential downside vs current price

Current Stock Price

$1.51

DCF Value-78.17%

$0.33

Potential downside vs current price

Analyst Consensus

Hold10 analysts

Hold

Updated Sep 12, 2026

Total Analysts10

Buy

1

Hold

8

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.51

DCF Value-78.17%

$0.33

Potential downside vs current price

Current Stock Price

$1.51

DCF Value-78.17%

$0.33

Potential downside vs current price

Alaunos Therapeutics, Inc.